{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T21:48:13Z","timestamp":1774993693148,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"crossref","award":["307262\/2011"],"award-info":[{"award-number":["307262\/2011"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Agency of the Sao Paulo Research Foundation","award":["2013\/11361-4"],"award-info":[{"award-number":["2013\/11361-4"]}]},{"name":"Agency of the Sao Paulo Research Foundation","award":["05\/56464-9"],"award-info":[{"award-number":["05\/56464-9"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.eplepsyres.2014.12.013","type":"journal-article","created":{"date-parts":[[2015,1,17]],"date-time":"2015-01-17T11:07:27Z","timestamp":1421492847000},"page":"18-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Hippocampal serotonin depletion is related to the presence of generalized tonic\u2013clonic seizures, but not to psychiatric disorders in patients with temporal lobe epilepsy"],"prefix":"10.1016","volume":"111","author":[{"given":"Natascha C.","family":"da Fonseca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena P.G.","family":"Joaquim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leda L.","family":"Talib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"de Vincentiis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wagner F.","family":"Gattaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kette D.","family":"Valente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.eplepsyres.2014.12.013_bib0005","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1471-4159.2006.04277.x","article-title":"Serotonin and epilepsy","volume":"100","author":"Bagdy","year":"2007","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.eplepsyres.2014.12.013_bib0010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000222775","article-title":"Refractory epilepsy: a clinically oriented review","volume":"62","author":"Beleza","year":"2009","journal-title":"Eur. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.eplepsyres.2014.12.013_bib0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0006-8993(00)02678-0","article-title":"Monoamine neurotransmitters in resected hippocampal subparcellations from neocortical and mesial temporal lobe epilepsy patients: in situ microvoltammetric studies","volume":"878","author":"Broderick","year":"2000","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.eplepsyres.2014.12.013_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(97)01215-6","article-title":"Enhancement of the anticonvulsant effect of fluoxetine following blockade of 5HT1a receptors","volume":"336","author":"Browning","year":"1997","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.eplepsyres.2014.12.013_bib0025","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.expneurol.2010.05.023","article-title":"Brain glycogen and neurotransmitter levels in fast and slo methionine sulfoximine-selected mice","volume":"225","author":"Cloix","year":"2010","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.eplepsyres.2014.12.013_bib0030","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0920-1211(97)00076-4","article-title":"Neurite extension of developing noradrenergic neurons is impaired in genetically epilepsy-prone rats (GEPR-3s): an in vitro study in locus coeruleus","volume":"29","author":"Clough","year":"1998","journal-title":"Epilepsy Res."},{"issue":"2","key":"10.1016\/j.eplepsyres.2014.12.013_bib0035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1528-1157.1996.tb00011.x","article-title":"Amygdala kindling of forebrain seizures and the occurrence of brainstem seizures in genetically epilepsy-prone rats","volume":"37","author":"Coffey","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2014.12.013_bib0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0920-1211(89)90063-6","article-title":"Neurology of seizure predisposition in the genetically epilepsy-pone rat","volume":"3","author":"Dailey","year":"1989","journal-title":"Epilepsy Res."},{"issue":"4","key":"10.1016\/j.eplepsyres.2014.12.013_bib0045","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0024-3205(92)90340-U","article-title":"Serotoninergic abnormalities in the central nervous system of seizure-naive genetically epilepsy prone rats","volume":"50","author":"Dailey","year":"1992","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.eplepsyres.2014.12.013_bib0050","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0006-3223(99)00189-4","article-title":"PET imaging of serotonin 1A receptor binding in depression","volume":"46","author":"Drevets","year":"1999","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.eplepsyres.2014.12.013_bib0055","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1212\/WNL.45.10.1926","article-title":"Anticonvulsivant effect of fluoxetine in humans","volume":"45","author":"Favale","year":"1995","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.eplepsyres.2014.12.013_bib0060","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S1059-1311(02)00315-1","article-title":"The anticonvulsant effect of citalopram as an indirect evidence of serotoninergic impairment in human epileptogenesis","volume":"12","author":"Favale","year":"2003","journal-title":"Seizure"},{"issue":"12","key":"10.1016\/j.eplepsyres.2014.12.013_bib0065","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.jpsychires.2011.07.005","article-title":"Increased PLA2 activity in the hippocampus of patients with temporal lobe epilepsy and psychosis","volume":"45","author":"Gattaz","year":"2011","journal-title":"J. Psychiatr. Res."},{"issue":"11","key":"10.1016\/j.eplepsyres.2014.12.013_bib0070","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.biopsych.2007.02.015","article-title":"5HT1A Receptor binding in temporal lobe epilepsy patients with and without major depression","volume":"62","author":"Hasler","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.eplepsyres.2014.12.013_bib0075","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.neulet.2011.09.036","article-title":"Association between suicide attempt and a tri-allelic functional polymorphism in serotonin transporter gene promoter in Chinese patients with schizophrenia","volume":"504","author":"Hung","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.eplepsyres.2014.12.013_bib0080","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1527-3458.2000.tb00150.x","article-title":"Genetically epilepsy-prone rats (GEPRs) in drug research","volume":"6","author":"Jobe","year":"2000","journal-title":"CNS Drug Rev"},{"issue":"9","key":"10.1016\/j.eplepsyres.2014.12.013_bib0085","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0024-3205(86)90455-8","article-title":"Noradrenergic and serotoninergic determinants of seizure susceptibility and severity in genetically epilepsy-prone rats","volume":"39","author":"Jobe","year":"1986","journal-title":"Life Sci."},{"issue":"1\u20132","key":"10.1016\/j.eplepsyres.2014.12.013_bib0090","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF02229080","article-title":"The genetically epilepsy-prone rat (GEPR)","volume":"16","author":"Jobe","year":"1995","journal-title":"Ital. J. Neurol. Sci."},{"issue":"12","key":"10.1016\/j.eplepsyres.2014.12.013_bib0095","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/hipo.22160","article-title":"Distinct increased metabotropic glutamate receptor type 5 (mGluR5) in temporal lobe epilepsy with and without hippocampal sclerosis","volume":"23","author":"Kandratavicius","year":"2013","journal-title":"Hippocampus"},{"issue":"11","key":"10.1016\/j.eplepsyres.2014.12.013_bib0100","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/NEN.0000000000000002","article-title":"Neurotrophins in mesial temporal lobe epilepsy with and without psychiatric comorbidities","volume":"72","author":"Kandratavicius","year":"2013","journal-title":"J. Neuropathol. Exp Neurol."},{"issue":"6","key":"10.1016\/j.eplepsyres.2014.12.013_bib0105","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE Commission on Therapeutics Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.eplepsyres.2014.12.013_bib0110","doi-asserted-by":"crossref","first-page":"e93158","DOI":"10.1371\/journal.pone.0093158","article-title":"The anticonvulsant effects of SR 57227 on pentylenetetrazole-induced seizure in mice","volume":"9","author":"Li","year":"2014","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.eplepsyres.2014.12.013_bib0115","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1017\/S0317167100029449","article-title":"A study of monoamines metabolism in human epilepsy","volume":"16","author":"Louw","year":"1989","journal-title":"Can. J. Neurol. Sci."},{"issue":"2\u20133","key":"10.1016\/j.eplepsyres.2014.12.013_bib0120","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eplepsyres.2007.07.002","article-title":"Localization of the serotoninergic terminal fields modulating seizures in the genetically epilepsy-prone rat","volume":"76","author":"Merrill","year":"2007","journal-title":"Epilepsy Res."},{"issue":"2","key":"10.1016\/j.eplepsyres.2014.12.013_bib0125","first-page":"157","article-title":"Decreased dopamine level in the epileptic focus","volume":"56","author":"Mori","year":"1987","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"issue":"2","key":"10.1016\/j.eplepsyres.2014.12.013_bib0130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0920-1211(96)00030-7","article-title":"Monoamines and their metabolites in cerebrospinal fluid and temporal cortex of epileptic patients","volume":"25","author":"Naffah-Mazzacoratti","year":"1996","journal-title":"Epilepsy Res."},{"issue":"1\u20132","key":"10.1016\/j.eplepsyres.2014.12.013_bib0135","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0006-8993(01)02214-4","article-title":"Biogenic amines in the human neocortex in paients with neocortical and mesial temporal lobe epilepsy: identification with in situ microvoltammetry","volume":"899","author":"Pacia","year":"2001","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.eplepsyres.2014.12.013_bib0140","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1111\/j.1528-1167.2012.03634.x","article-title":"Multireceptor analysis in human neocortex reveals complex alterations of receptor ligand binding in focal epilepsies","volume":"3","author":"Palomero-Gallagher","year":"2012","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.eplepsyres.2014.12.013_bib0145","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.neures.2011.03.002","article-title":"Serotonergic neurotransmission plays a major role in the action of the glycogenic convulsant methionine sulfoximine","volume":"70","author":"Picard","year":"2011","journal-title":"Neurosci. Res."},{"issue":"2","key":"10.1016\/j.eplepsyres.2014.12.013_bib0150","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/syn.890050210","article-title":"Levels of biogenic amines, their metabolites, and tyrosine hydroxylase in the human epileptic temporal cortex","volume":"5","author":"Pintor","year":"1990","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/j.eplepsyres.2014.12.013_bib0155","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.nbd.2011.09.006","article-title":"Dopamine abnormalities in the neocortex of patients with temporal lobe epilepsy","volume":"45","author":"Rocha","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.eplepsyres.2014.12.013_bib0160","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/exnr.1998.7003","article-title":"Morphological deficits in noradrenergic neurons in GEPR-9s stem from abnormalities in both the locus coeruleus and its target tissues","volume":"156","author":"Ryu","year":"1999","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.eplepsyres.2014.12.013_bib0165","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archpsyc.57.2.174","article-title":"Brain serotonin 1A receptor binding measured by positron emission tomography with [11C]WAY-100635","volume":"57","author":"Sargent","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.eplepsyres.2014.12.013_bib0170","first-page":"1","article-title":"Serotonin gene polymorphisms and psychiatry comomorbidities in temporal lobe epilepsy","volume":"12","author":"Schenkel","year":"2011","journal-title":"Epilepsy Res."},{"issue":"6","key":"10.1016\/j.eplepsyres.2014.12.013_bib0175","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.neuropharm.2008.02.006","article-title":"Direct enhancement of hippocampal dopamine or serotonin levels as a pharmacodynamic measure of combined antidepressant-anticonvulsant action","volume":"54","author":"Smolders","year":"2008","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.eplepsyres.2014.12.013_bib0180","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00002826-200405000-00009","article-title":"Citalopram as treatment of depression in patients with epilepsy","volume":"27","author":"Specchio","year":"2004","journal-title":"Clin. Neuropharmacol."},{"issue":"2\u20133","key":"10.1016\/j.eplepsyres.2014.12.013_bib0185","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.eplepsyres.2008.08.010","article-title":"Serotonin depletion effects on the pilocarpine model of epilepsy","volume":"82","author":"Trindade-Filho","year":"2008","journal-title":"Epilepsy Res."},{"issue":"5","key":"10.1016\/j.eplepsyres.2014.12.013_bib0190","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1528-1167.2009.02512.x","article-title":"Characteristics of a large population of patients with refractory epilepsy attending tertiary referral centers in Italy","volume":"51","author":"Veriano","year":"2010","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.eplepsyres.2014.12.013_bib0195","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1528-1167.2012.03436.x","article-title":"The antidepressants citalopram and reboxetine reduce seizure frequency in rats with chronic epilepsy","volume":"53","author":"Vermoesen","year":"2012","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.eplepsyres.2014.12.013_bib0200","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0014-2999(94)90581-9","article-title":"Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats","volume":"252","author":"Yan","year":"1994","journal-title":"Eur. J. Pharmacol."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121115000029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121115000029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:32:50Z","timestamp":1760275970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121115000029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":40,"alternative-id":["S0920121115000029"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2014.12.013","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hippocampal serotonin depletion is related to the presence of generalized tonic\u2013clonic seizures, but not to psychiatric disorders in patients with temporal lobe epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2014.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}